Partnerships & Joint Ventures
-
Eagle in rudest of health after tie-up with hygiene specialist
UK-based global health and hygiene company RB is collaborating with Eagle Genomics in Cambridge in a research project designed to simplify... Read More
-
Cambridge startup inspires AI-led approach to cancer trials
Cambridge Cancer Genomics is leveraging its AI platform in a new partnership designed to more accurately target tumours in precision clinical trials... Read More
-
Arecor targets oncology and rare orphan diseases in US alliance
Cambridge biopharma business Arecor has extended its multi-product collaboration with a US-based clinical stage biotechnology company. Under the... Read More
-
Italian pioneer works with TTP to boost global health diagnostics
Technology hothouse TTP is at the heart of a European initiative to revolutionise in vitro diagnostic medical device (IVD) technology to boost... Read More
-
Heart and Seoul as Avacta launches Korean JV
Cambridge based BioMedTech business Avacta Group has joined forces with Daewoong Pharmaceutical to establish a significant joint venture in South... Read More
-
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases... Read More
-
Cambridge duo develop novel cell technology
Life sciences influencer Abcam and Cambridge neighbour SomaServe, a pharma service and specialist reagent business exploiting PolyNaut Technology,... Read More
-
Abcodia and AstraZeneca China fight for earlier cancer detection
Cambridge UK business Abcodia, a leader in early cancer detection, has formed a strategic partnership with AstraZeneca China focusing on the early... Read More
-
PhoreMost and Sentinel extend cancer collaboration
PhoreMost, the Cambridge biopharma company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, have expanded a collaboration... Read More
-
Sphere Fluidics hits a fresh Peak with cell analysis collaboration
Sphere Fluidics, which is commercialising single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and... Read More
-
Qualcomm and Tencent form digital entertainment alliance
Two global influencers with major investment in China as well as the Cambridge technology cluster have formed a strategic collaboration designed to... Read More
-
Astex already cashing in on $16bn market
Cambridge-based Astex Pharmaceuticals, dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of... Read More
-
Foetal attraction as Horizon Discovery leads prenatal testing initiative
Horizon Discovery Group in Cambridge is at the heart of a new alliance developing crucial reference material for non-invasive prenatal testing (NIPT... Read More
-
Abcam forges US alliance with New Jersey contract research organisation
Abcam, the Cambridge life science reagents and tools specialist has unveiled a key collaboration with a US partner. It has teamed with Visikol, a... Read More
-
Quadram Institute in alliance to tackle global food and health challenges
Quadram Institute Bioscience at Norwich Research Park and the University of Newcastle in Australia have signed a Memorandum of Understanding to... Read More
-
PragmatIC and German ally form RFID partnership
Cambridge-based PragmatIC, a pioneer in ultra-low cost flexible electronics, and German powerhouse Mühlbauer, a proven technology supplier of RFID... Read More
-
Rothamsted and Cranfield help drive Morocco AgriTech project
An international academic partnership has been announced by Mohammed VI Polytechnic University in Morocco and two of the East of England and UK’s... Read More
-
Abcam helping to develop research tools for major deficiency disorder
Cambridge antibody technology from Abcam is at the heart of a UK partnership designed to develop solutions to fight a serious deficiency disorder... Read More
-
Horizon clinches gamechanging cell therapy alliance with US university
A collaboration between Cambridge-based gene editing world leader Horizon Discovery and Rutgers – the state university of New Jersey – promises to... Read More
-
Horizon alliance seeks fresh drugs to treat lung and colorectal cancer
Cambridge-based gene editing world leader Horizon Discovery has struck an exclusive target discovery partnership with fellow AIM company C4X... Read More